Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents. 2008

Ping Liu, and Shaolong Zhu, and Peng Li, and Weijie Xie, and Yongsheng Jin, and Qingyan Sun, and Qiuye Wu, and Peng Sun, and Yingjun Zhang, and Xiaohong Yang, and Yuanying Jiang, and Dazhi Zhang
Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, PR China.

A series of 1-(substituted biaryloxy)-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl) propan-2-ol were synthesized and their antifungal activities were evaluated against eight human pathogenic fungi in vitro. Seventeen compounds showed activity 4- to 64-fold higher than voriconazole against Candida albicans. SAR clearly suggested that introduction of a biaryloxy side chain greatly enhanced the antifungal activity of triazole analogs against Candida species.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D015003 Yeasts A general term for single-celled rounded fungi that reproduce by budding. Brewers' and bakers' yeasts are SACCHAROMYCES CEREVISIAE; therapeutic dried yeast is YEAST, DRIED. Yeast
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015725 Fluconazole Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS. Apo-Fluconazole,Béagyne,Diflucan,Fluc Hexal,FlucoLich,Flucobeta,Fluconazol AL,Fluconazol AbZ,Fluconazol Stada,Fluconazol von ct,Fluconazol-Isis,Fluconazol-ratiopharm,Flunazul,Fungata,Lavisa,Loitin,Neofomiral,Oxifungol,Solacap,Triflucan,UK-49858,Zonal,Apo Fluconazole,Fluconazol Isis,Fluconazol ratiopharm,UK 49858,UK49858

Related Publications

Ping Liu, and Shaolong Zhu, and Peng Li, and Weijie Xie, and Yongsheng Jin, and Qingyan Sun, and Qiuye Wu, and Peng Sun, and Yingjun Zhang, and Xiaohong Yang, and Yuanying Jiang, and Dazhi Zhang
January 2001, Bollettino chimico farmaceutico,
Ping Liu, and Shaolong Zhu, and Peng Li, and Weijie Xie, and Yongsheng Jin, and Qingyan Sun, and Qiuye Wu, and Peng Sun, and Yingjun Zhang, and Xiaohong Yang, and Yuanying Jiang, and Dazhi Zhang
January 2010, Bioorganic & medicinal chemistry letters,
Ping Liu, and Shaolong Zhu, and Peng Li, and Weijie Xie, and Yongsheng Jin, and Qingyan Sun, and Qiuye Wu, and Peng Sun, and Yingjun Zhang, and Xiaohong Yang, and Yuanying Jiang, and Dazhi Zhang
September 1984, Research communications in chemical pathology and pharmacology,
Ping Liu, and Shaolong Zhu, and Peng Li, and Weijie Xie, and Yongsheng Jin, and Qingyan Sun, and Qiuye Wu, and Peng Sun, and Yingjun Zhang, and Xiaohong Yang, and Yuanying Jiang, and Dazhi Zhang
July 2017, Bioorganic & medicinal chemistry letters,
Ping Liu, and Shaolong Zhu, and Peng Li, and Weijie Xie, and Yongsheng Jin, and Qingyan Sun, and Qiuye Wu, and Peng Sun, and Yingjun Zhang, and Xiaohong Yang, and Yuanying Jiang, and Dazhi Zhang
September 2019, Journal of medicinal chemistry,
Ping Liu, and Shaolong Zhu, and Peng Li, and Weijie Xie, and Yongsheng Jin, and Qingyan Sun, and Qiuye Wu, and Peng Sun, and Yingjun Zhang, and Xiaohong Yang, and Yuanying Jiang, and Dazhi Zhang
January 2022, BioMed research international,
Ping Liu, and Shaolong Zhu, and Peng Li, and Weijie Xie, and Yongsheng Jin, and Qingyan Sun, and Qiuye Wu, and Peng Sun, and Yingjun Zhang, and Xiaohong Yang, and Yuanying Jiang, and Dazhi Zhang
September 1999, Bioorganic & medicinal chemistry letters,
Ping Liu, and Shaolong Zhu, and Peng Li, and Weijie Xie, and Yongsheng Jin, and Qingyan Sun, and Qiuye Wu, and Peng Sun, and Yingjun Zhang, and Xiaohong Yang, and Yuanying Jiang, and Dazhi Zhang
June 2007, Bioorganic & medicinal chemistry letters,
Ping Liu, and Shaolong Zhu, and Peng Li, and Weijie Xie, and Yongsheng Jin, and Qingyan Sun, and Qiuye Wu, and Peng Sun, and Yingjun Zhang, and Xiaohong Yang, and Yuanying Jiang, and Dazhi Zhang
May 2015, ChemMedChem,
Ping Liu, and Shaolong Zhu, and Peng Li, and Weijie Xie, and Yongsheng Jin, and Qingyan Sun, and Qiuye Wu, and Peng Sun, and Yingjun Zhang, and Xiaohong Yang, and Yuanying Jiang, and Dazhi Zhang
September 2009, Archiv der Pharmazie,
Copied contents to your clipboard!